PeterWymanWilsonMD

PubMed

• 207 citations
  Association of HbA1c with prevalent cardiovascular disease in the original cohort of the Framingham heart study
  Daniel E. Singer, David M. Nathan, Keaven M. Anderson, Peter W.F. Wilson, Jane C. Evans
  Diabetes. 1992-02-01
• 867 citations
  Prediction of Lifetime Risk for Cardiovascular Disease by Risk Factor Burden at 50 Years of Age
  Donald M. Lloyd-Jones, Eric P. Leip, Martin G. Larson, Ralph B. D'Agostino, Alexa S. Beiser
  Circulation. 2006-02-14
• 145 citations
  Sex Differences in the Use of Statins in Community Practice.
  Michael G. Nanna, Tracy Y. Wang, Qun Xiang, Anne C. Goldberg, Jennifer G. Robinson
  Circulation. Cardiovascular Quality and Outcomes. 2019-08-01

Journal Articles

• prediction of coronary heart disease  
  Wilson, P.W., Circulation, 1998

Books/Book Chapters

• Dyslipidaemia in Clinical Practice 
  Wilson PWFEditors: Thompson G, Morrell J, Wilson P.Informa HealthcareEdition 2nd,2006
• Atlas of Cardiovascular Risk Factors 
  Chapter: Coronary heart disease risk: Origins, factors and utility. 
  Page 37 - 48Wilson PWFEditors: Gaziano JM.Current Medicine2006
• Women and Heart Disease 
  Chapter: Cardiovascular disease risk factors in women 
  Page 17 - 31Wilson PWFEditors: Wenger NK, Collins P.Taylor and Francis, Abingdon, UK2005
• Essential Atlas of Heart Diseases 
  Chapter: Atherosclerosis: Risk factors and treatment 
  Page 1 - 24Wilson PWFEditors: Braunwald, E.Current MedicineEdition 3rd,2005
• Atlas of Atherosclerosis 
  Chapter: Diabetes mellitus and vascular disease risk 
  Page 214 - 233Meigs JB, Wilson PWF, Goldberg IJ, Semenkovich CF, Ginsberg HNEditors: Grundy S.Current MedicineEdition 4th,2005
• Atlas of Atherosclerosis 
  Chapter: The newer coronary risk factors 
  Page 169 - 185Wilson PWFEditors: Grundy S.Current MedicineEdition 4th,2005
• Molecular mechanisms of atherosclerosis 
  Chapter: The epidemiology of atherosclerotic disease. Chapter 2 
  Page 3 - 28Wilson PWFEditors: J Loscalzo.Taylor & Francis, London2005
• Harrison's Advances in Cardiology 
  Chapter: Homocysteine, vitamins and coronary artery disease. 
  Page 18 - 23Wilson P.W.F.Editors: Braunwald E.McGraw-Hill, New York2002
• Homocysteine and Vascular Disease 
  Chapter: Epidemiology of homocysteine levels and relation to vitamins 
  Page 85 - 95Wilson PWF, Jacques PFEditors: K. Robinson.Kluwer Academic Publishers, Amsterdam2000
• Handbook of Hypertension, Volume 20: Epidemiology of Hypertension 
  Chapter: Hypertension as a cardiovascular risk factor 
  Page 19 - 42Kannel WB, Wilson PWFEditors: C. J. Bulpitt.Elsevier Press, Amsterdam2000
• Atlas of Atherosclerosis: Risk Factors and Treatment 
  Chapter: The newer coronary risk factors 
  Page 180 - 193Wilson PWFEditors: PWF Wilson.Current Science 2000, Philadelphia, PAEdition 2nd,2000
• Statins: The HMG CoA Reductase Inhibitors in Perspective 
  Chapter: Lipid control in the pre-statin era. 
  Page 21 - 34Kannel WB, Wilson PWFEditors: Gaw A, Packard CJ, Shepherd J.Dunitz Press, London1999
• Cardiovascular Disease in the Octogenarian and Beyond 
  Chapter: Coronary risk factors and coronary prevention in octogenarians 
  Page 141 - 161Kannel WB, Wilson PWF, Larson MG, Evans JCEditors: Wenger NK.Dunitz Press1999
• Atherosclerosis XI 
  Chapter: Secular trends in cardiovascular risk factor levels: a Framingham perspective. 
  Page 659 - 664Wilson PWF, D’Agostino RB, Kannel WBEditors: B. Jacotot, D. Mathe, J-C Fruchart.Elsevier Press, Singapore1998
• Preventive Cardiology 
  Chapter: Diabetes mellitus, insulin resistance and CHD 
  Page 69 - 96Wilson PWFEditors: Robinson K.Futura, New York1998
• Preventive Cardiology 
  Chapter: Physical activity and CHD 
  Page 51 - 67Wilson PWFEditors: Robinson K.Futura, New York1998
• Atherosclerosis XI 
  Chapter: Advances in cardiovascular risk prediction: new biochemical and genetic markers. 
  Page 425 - 431Ordovas JM, Cupples LA, Wilson PWF, Lahoz C, Levy D, Otvos JD, McNamara JR, Gagne E, Hayden M, Schaefer EJEditors: B. Jacotot, D. Mathe, J-C Fruchart.Elsevier Press, Singapore1998
• Multiple Risk Factors in Cardiovascular Disease 
  Chapter: Epidemiology of risk factor clustering in elevated blood pressure 
  Page 325 - 333Editors: Gotto Jr AM et al.Kluwer, Netherlands1998
• Textbook of Cardiovascular Medicine 
  Chapter: Atherosclerotic Cardiovascular Disease : An epidemiologic perspecitive 
  Page 13 - 30Levy D, Wilson PWFEditors: Topol E.Lippincott-Raven1997
• Surrogate markers to assess efficacy of treatment in chronic liver disease. 
  Chapter: Surrogate markers and prediction of cardiovascular disease (chapter 2) 
  Page 8 - 18Wilson PWFEditors: Reichen R.E.. & Reichen J.Kluwer1996
• Atlas of Heart Diseases; Volume X Atherosclerosis: Risk factors and treatment 
  Chapter: The Newer Coronary Risk Factors (chapter 10). 
  Wilson PWF, Castelli WPEditors: E. Braunwald; Brown,W.V. (Volume Editor).Mosby, St. Louis1996
•  
  Chapter: Apolipoprotein E allele 4 is associated with dementia in the Framingham Study 
  Page 63 - 70Myers RH, Schaefer EJ, Wilson PWF, D'Agostino R, Bachman DL, Ordovas JM, Au R, Cobb JL, Wolf PAEditors: Iqbal K, Mortimer JA, Winblad B, Wisniewski HM.Wiley & Sons1995
• Hypertension: Physiology, Diagnosis, and Management. 
  Chapter: Chapter 7: Hypertension, other risk factors, and the risk of cardiovascular disease. 
  Page 99 - 114Wilson PWF, Kannel WBEditors: Laragh JH and Brenner BM.Raven Press, New YorkEdition 2nd,1995
• Hypertension Primer: The Essentials of High Blood Pressure 
  Chapter: Chapter C17: Total Cardiovascular Risk 
  Page 190 - 191Wilson PWFEditors: Izzo JL and Black HR.American Heart Association1993
• Coronary Risk Factors and Their Assessment 
  Thompson GR, Wilson PWFScience Press, London1992
• Join now to see all